LOIS M RAMONDETTA to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about TOR Serine-Threonine Kinases.
Connection Strength
0.112
-
Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. Int J Clin Exp Pathol. 2010 Nov 20; 4(1):13-21.
Score: 0.057
-
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9.
Score: 0.055